Literature DB >> 21498835

Candida urinary tract infections--epidemiology, pathogenesis, diagnosis, and treatment: executive summary.

John F Fisher1.   

Abstract

The frequency of infection of the urinary tract due to Candida species is increasing in parallel with the rapid advances of medical progress, and these infections are now among the most common problems facing physicians. Despite this fact, much remains to be learned regarding the pathogenesis, diagnosis, and management of bloodborne (antegrade) kidney infections and ascending (retrograde) invasion of the urinary collecting system. The following is a summary of the in-depth analysis of available information from the literature provided in this journal supplement.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21498835     DOI: 10.1093/cid/cir108

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

1.  Candida growth in urine cultures: a contemporary analysis of species and antifungal susceptibility profiles.

Authors:  L Toner; N Papa; S H Aliyu; H Dev; N Lawrentschuk; Samih Al-Hayek
Journal:  QJM       Date:  2015-11-04

2.  Mechanisms of Acquired In Vivo and In Vitro Resistance to Voriconazole by Candida krusei following Exposure to Suboptimal Drug Concentration.

Authors:  Elisabete Ricardo; Fréderic Grenouillet; Isabel M Miranda; Raquel M Silva; Guilluame Eglin; Nadège Devillard; Acácio Gonçalves Rodrigues; Cidália Pina-Vaz
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

3.  Hibiscus sabdariffa extract inhibits in vitro biofilm formation capacity of Candida albicans isolated from recurrent urinary tract infections.

Authors:  Issam Alshami; Ahmed E Alharbi
Journal:  Asian Pac J Trop Biomed       Date:  2014-02

4.  High prevalence of candiduria due to non-albicans Candida species among diabetic patients: A matter of concern?

Authors:  Alireza Esmailzadeh; Hossein Zarrinfar; AbdolMajid Fata; Tanuka Sen
Journal:  J Clin Lab Anal       Date:  2017-10-27       Impact factor: 2.352

5.  Antifungal activity of a β-peptide in synthetic urine media: Toward materials-based approaches to reducing catheter-associated urinary tract fungal infections.

Authors:  Namrata Raman; Myung-Ryul Lee; Angélica de L Rodríguez López; Sean P Palecek; David M Lynn
Journal:  Acta Biomater       Date:  2016-07-12       Impact factor: 8.947

6.  Assessment of Caspofungin use at a Tertiary Teaching Hospital and compliance with IDSA guidelines and FDA labelings.

Authors:  Abrar F Alshehri; Thamer A Almangour; Abdullah A Alhifany; Abdulaziz Alhossan
Journal:  Saudi Pharm J       Date:  2022-01-05       Impact factor: 4.562

7.  Epidemiology and changes in patient-related factors from 1997 to 2009 in clinical yeast isolates related to dermatology, gynaecology, and paediatrics.

Authors:  Viktor Czaika; Pietro Nenoff; Andreas Glöckner; Wolfgang Fegeler; Karsten Becker; Arno F Schmalreck
Journal:  Int J Microbiol       Date:  2013-12-11

8.  Medical Device-Associated Candida Infections in a Rural Tertiary Care Teaching Hospital of India.

Authors:  Sachin C Deorukhkar; Santosh Saini
Journal:  Interdiscip Perspect Infect Dis       Date:  2016-01-24

9.  Vesical fungus balls (fungal bezoars) by Candida albicans mimicking urothelial carcinoma in a patient with diabetic neurogenic bladder.

Authors:  Kosuke Takemura; Ryoji Takazawa; Yusuke Kohno; Satoshi Yoshida; Hiroyuki Kato; Toshihiko Tsujii
Journal:  Urol Case Rep       Date:  2018-03-09

10.  Cranberry-derived proanthocyanidins induce a differential transcriptomic response within Candida albicans urinary biofilms.

Authors:  Anitha Sundararajan; Hallie S Rane; Thiruvarangan Ramaraj; Johnny Sena; Amy B Howell; Stella M Bernardo; Faye D Schilkey; Samuel A Lee
Journal:  PLoS One       Date:  2018-08-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.